Literature DB >> 20818658

Olfactory heterogeneity in LRRK2 related Parkinsonism.

Laura Silveira-Moriyama1, Renato Pupi Munhoz, Margarete de J Carvalho, Salmo Raskin, Ekaterina Rogaeva, Patricia de C Aguiar, Rodrigo A Bressan, Andre C Felicio, Orlando G P Barsottini, Luiz Augusto F Andrade, Hsin F Chien, Vincenzo Bonifati, Egberto R Barbosa, Helio A Teive, Andrew J Lees.   

Abstract

LRRK2 mutations can cause familial and sporadic Parkinson's disease (PD) with Lewy-body pathology at post-mortem. Studies of olfaction in LRRK2 are sparse and incongruent. We applied a previously validated translation of the 16 item smell identification test from Sniffin' Sticks (SS-16) to 14 parkinsonian carriers of heterozygous G2019S LRRK2 mutation and compared with 106 PD patients and 118 healthy controls. The mean SS-16 score in LRRK2 was higher than in PD (p < 0.001, 95% CI for β = -4.7 to -1.7) and lower than in controls (p = 0.007, 95% CI for β = +0.6 to +3.6). In the LRRK2 group, subjects with low scores had significantly more dyskinesia. They also had younger age of onset, longer disease duration, and reported less frequently a family history of PD, but none of these other differences reached significance. Odor identification is diminished in LRRK2 parkinsonism but not to the same extent as in idiopathic PD.
© 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818658     DOI: 10.1002/mds.23325

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Olfactory dysfunction in LRRK2 G2019S mutation carriers.

Authors:  R Saunders-Pullman; K Stanley; C Wang; M San Luciano; V Shanker; A Hunt; L Severt; D Raymond; L J Ozelius; R B Lipton; S B Bressman
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 2.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

3.  Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant.

Authors:  Rachel Saunders-Pullman; Roberto Angel Ortega; Cuiling Wang; Deborah Raymond; Sonya Elango; Katherine Leaver; Nikita Urval; Viktoriya Katsnelson; Rachel Gerber; Matthew Swan; Vicki Shanker; Roy N Alcalay; Anat Mirelman; Michael C Brumm; Helen Mejia-Santana; Christopher S Coffey; Kenneth Marek; Laurie J Ozelius; Nir Giladi; Karen S Marder; Susan B Bressman
Journal:  Neurology       Date:  2022-06-03       Impact factor: 11.800

Review 4.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 5.  Olfactory dysfunction in Parkinson disease.

Authors:  Richard L Doty
Journal:  Nat Rev Neurol       Date:  2012-05-15       Impact factor: 42.937

6.  Screening for VPS35 mutations in Parkinson's disease.

Authors:  Una-Marie Sheerin; Gavin Charlesworth; Jose Bras; Rita Guerreiro; Kailash Bhatia; Thomas Foltynie; Patricia Limousin; Laura Silveira-Moriyama; Andrew Lees; Nicholas Wood
Journal:  Neurobiol Aging       Date:  2011-12-07       Impact factor: 4.673

7.  Drosophila Mutant Model of Parkinson's Disease Revealed an Unexpected Olfactory Performance: Morphofunctional Evidences.

Authors:  Francescaelena De Rose; Valentina Corda; Paolo Solari; Patrizia Sacchetti; Antonio Belcari; Simone Poddighe; Sanjay Kasture; Paolo Solla; Francesco Marrosu; Anna Liscia
Journal:  Parkinsons Dis       Date:  2016-08-28

8.  Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.

Authors:  Daryl J Wile; Pankaj A Agarwal; Michael Schulzer; Edwin Mak; Katherine Dinelle; Elham Shahinfard; Nasim Vafai; Kazuko Hasegawa; Jing Zhang; Jessamyn McKenzie; Nicole Neilson; Audrey Strongosky; Ryan J Uitti; Mark Guttman; Cyrus P Zabetian; Yu-Shin Ding; Mike Adam; Jan Aasly; Zbigniew K Wszolek; Matthew Farrer; Vesna Sossi; A Jon Stoessl
Journal:  Lancet Neurol       Date:  2017-03-20       Impact factor: 44.182

Review 9.  LRRK2: cause, risk, and mechanism.

Authors:  Coro Paisán-Ruiz; Patrick A Lewis; Andrew B Singleton
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

10.  Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?

Authors:  Rachel Saunders-Pullman; Anat Mirelman; Cuiling Wang; Roy N Alcalay; Marta San Luciano; Robert Ortega; Deborah Raymond; Helen Mejia-Santana; Laurie Ozelius; Lorraine Clark; Avi Orr-Utreger; Karen Marder; Nir Giladi; Susan B Bressman
Journal:  Ann Clin Transl Neurol       Date:  2014-09-30       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.